Nadim Ahmed - Net Worth and Insider Trading
Nadim Ahmed Net Worth
The estimated net worth of Nadim Ahmed is at least $2 Million dollars as of 2024-04-25. Nadim Ahmed is the President and CEO of Cullinan Therapeutics Inc and owns about 111,550 shares of Cullinan Therapeutics Inc (CGEM) stock worth over $2 Million. Details can be seen in Nadim Ahmed's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nadim Ahmed has not made any transactions after 2023-12-26 and currently still holds the listed stock(s).
Transaction Summary of Nadim Ahmed
Nadim Ahmed Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nadim Ahmed owns 2 companies in total, including Bristol-Myers Squibb Co (BMY) , and Cullinan Oncology Inc (CGEM) .
Click here to see the complete history of Nadim Ahmed’s form 4 insider trades.
Insider Ownership Summary of Nadim Ahmed
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMY | Bristol-Myers Squibb Co | 2019-11-20 | President & Hematology |
| CGEM | Cullinan Oncology Inc | 2023-12-26 | director & President and CEO |
Nadim Ahmed Latest Holdings Summary
Nadim Ahmed currently owns a total of 1 stock. Nadim Ahmed owns 111,550 shares of Cullinan Therapeutics Inc (CGEM) as of December 26, 2023, with a value of $2 Million.
Latest Holdings of Nadim Ahmed
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics Inc | 2023-12-26 | 111,550 | 18.89 | 2,107,180 |
Holding Weightings of Nadim Ahmed
Nadim Ahmed Form 4 Trading Tracker
According to the SEC Form 4 filings, Nadim Ahmed has made a total of 6 transactions in Cullinan Therapeutics Inc (CGEM) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Cullinan Therapeutics Inc is the sale of 4,272 shares on December 26, 2023, which brought Nadim Ahmed around $39,473.
Insider Trading History of Nadim Ahmed
- 1
Nadim Ahmed Trading Performance
GuruFocus tracks the stock performance after each of Nadim Ahmed's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nadim Ahmed is 3.26%. GuruFocus also compares Nadim Ahmed's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nadim Ahmed within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nadim Ahmed's insider trading performs compared to the benchmark.
Performance of Nadim Ahmed
Average Return
0.08%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.36 | 3.26 | -3.83 | 0.08 | ||
| Relative Return to S&P 500(%) | 16.07 | 8.43 | 0.54 | -3.86 |
Nadim Ahmed Ownership Network
Ownership Network List of Nadim Ahmed
Ownership Network Relation of Nadim Ahmed
Nadim Ahmed Owned Company Details
What does Bristol-Myers Squibb Co do?
Who are the key executives at Bristol-Myers Squibb Co?
Nadim Ahmed is the President & Hematology of Bristol-Myers Squibb Co. Other key executives at Bristol-Myers Squibb Co include EVP & Chief Commercial Officer Christopher S. Boerner , EVP & Corporate Affairs Cari Gallman , and SVP & Human Resources Ann Powell Judge .
Bristol-Myers Squibb Co (BMY) Insider Trades Summary
Over the past 18 months, Nadim Ahmed made no insider transaction in Bristol-Myers Squibb Co (BMY). Other recent insider transactions involving Bristol-Myers Squibb Co (BMY) include a net sale of 45,419 shares made by Ann Powell Judge , a net sale of 96,295 shares made by Rupert Vessey , and a net purchase of 5,071 shares made by Christopher S. Boerner .
In summary, during the past 3 months, insiders sold 0 shares of Bristol-Myers Squibb Co (BMY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 382,446 shares of Bristol-Myers Squibb Co (BMY) were sold and 13,571 shares were bought by its insiders, resulting in a net sale of 368,875 shares.
Bristol-Myers Squibb Co (BMY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bristol-Myers Squibb Co Insider Transactions
Nadim Ahmed Mailing Address
Above is the net worth, insider trading, and ownership report for Nadim Ahmed. You might contact Nadim Ahmed via mailing address: C/o Celgene Corporation, 86 Morris Avenue, Summit Nj 07901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
